Gino Kenny (Dublin Mid West, People Before Profit Alliance)
Link to this: Individually | In context | Oireachtas source

In regard to the scientific review which was done in 2017, obviously, things have moved on in terms of the evidence base around medicinal cannabis. Does the HPRA envisage that other conditions will be included in the programme? The programme itself is very restrictive and we could have a situation where only a handful can get access. We could have a situation where more people could have access via the ministerial programme than via the programme itself. Is there a basis to include other conditions? The omission of chronic pain in 2017 was very controversial. My understanding is that the Danish cannabis access programme includes neurological pain as there is an unmet need for that condition. Will the review look to include other conditions over the next six months?